Bosight Medical Launches World’s First Commercial Adaptive Optics Retinal Imaging System – Xingjing® AO-SLO

Adaptive Optics (AO) has been rated as one of the most influential technologies in the field of ophthalmic imaging in the 21st century, but research on adaptive optics systems has remained in the laboratory stage, unable to achieve miniaturization, commercialization, and large-scale clinical application.

After years of沉淀, Robotrak Technologies has深耕 the field of adaptive optics technology, continuously研发创新, and launched the first commercial adaptive optics fundus imaging system - StarScope®, which enhances the lateral resolution of fundus images to 0.7 microns. It can be used for researching disease pathogenesis, ultra-early diagnosis, intervention and follow-up observation, as well as evaluating innovative therapies such as gene and stem cell treatments, and is acclaimed as a cellular-level "Fundus In Vivo Biological Microscope"!

On April 8 (Monday) at 19:30, the 53rd episode of VCBeat's "New Product Review" will invite...Robotrak Technologies Founder, Chairman and CEO Zhang JieBring relevant product introductions.

AO-SLO System with a Resolution of up to 0.7μm

· Multiple Cutting-edge Technologies Achieve High-definition Imaging: Adaptive Optics Technology, Real-time Eye Tracking Technology

· Real-time Navigation System + Image Stitching Technology for Large-scale Imaging

· Retinal Layer Imaging Technology Can Clearly Present Images of Different Depth Structures Such as Capillaries, Photoreceptor Cells, and Nerve Fibers

· A Variety of Quantitative Functions Empower Clinical Diagnosis and Treatment

· A Variety of Applications and Studies Await Further Exploration

Scan the QR code on the poster to add the assistant and schedule a live broadcast.

Zhang Jie

Founder, Chairman, and CEO of Robotrak Technologies

Education Background:Bachelor's and Master's degrees from Nanjing University, Ph.D. from the University of Rochester, USA; studied under Professor David R. Williams, a member of the National Academy of Sciences and the National Academy of Engineering, and a world-renowned ophthalmology expert; Postdoctoral researcher and Associate Researcher at the Center for Visual Science, University of Rochester, USA.

Technical Achievements:Reached international leading levels in high-precision eye tracking, precise laser treatment, and adaptive optics retinal imaging technologies; an expert in ophthalmic optics and lasers, and a pioneer in the commercialization of cellular-level 3D retinal imaging. Participated in the development of U.S. laser safety standards; applied for over 80 patents (of which more than 30 have been granted), and published nearly 50 SCI papers and academic reports.

Title:

In February 2018, selected for the "Nanjing High-Level Entrepreneurial Talent Program"

In July 2019, selected for the "Jiangsu Province Double Innovation Plan (Entrepreneurship Category)"

In August 2019, received the approval for the "Jiangsu Province Overseas Returnees Entrepreneurship and Innovation Program"

In May 2022, it was approved for the "Key Research and Development Plan of Jiangsu Province (Social Development) Project."

In June 2022, the project was approved for inclusion in the "MIIT & NMPA Artificial Intelligence Medical Device Innovation Task List."

In October 2023, received the "Nanjing Science and Technology Special Project for Important Personnel (Life Health)" approval.

Robotrak Technologies Co., Ltd. is an ophthalmic innovation platform company catering to all age groups. Adhering to the original aspiration of "Everyone deserves a clearer world," and with the mission of "Technological innovation, affordable healthcare, rooted in China, with a global perspective," the company is committed to providing innovative solutions in areas such as diagnosis and treatment of fundus diseases, myopia prevention and control for adolescents, functional contact lenses, digital ophthalmic healthcare, and customized research equipment. Robotrak Technologies possesses core technologies including adaptive optics, optical design and precision machining, optical measurement and imaging, eye-tracking, precise laser positioning, artificial intelligence, image algorithms, and material processes, creating two major business segments: ophthalmic devices and contact lenses, covering medical, consumer, and research markets.

"Artery严选 New Product Review" is a live broadcast column under "Artery严选" that supports the release of innovative medical products. The column's mission is to assist in the milestone release of every medical innovation product.

Scan the QR code below to contact the assistant and schedule a live broadcast.

(If already added, please actively ask the assistant)